Evaluation of a deodorizing and underarm skin benefitting efficacy of a new formulation.

INTERVENTION: Intervention1: 16‐066: Test product will be applied to cover the designated axilla. Once daily for 45 days. Control Intervention1: Untreated site: NIL CONDITION: PRIMARY OUTCOME: Axillary odor intensity, as assessed by an olfactory expert panelTimepoint: Day 01 ‐ Before and after product application, Day 02, Day 46 and Day 47 SECONDARY OUTCOME: Assessment of product stickiness by an expertTimepoint: Day 01 ‐ after product application Axillary pigmentation as per Instrumental measurements and Dermatological assessmentTimepoint: Day 01 ‐ Before and after product application, Day 02, Day 05, Day 10, Day 15, Day 30, Day 45, Day 46 and Day 47 Dermatological assessment of axillary skin smoothnessTimepoint: Day 01 ‐ Before and after product application, Day 02, Day 05, Day 10, Day 15, Day 30, Day 45, Day 46 and Day 47 Instrumental and Dermatological assessment of axillary skin hydration stateTimepoint: Day 01 ‐ Before and after product application, Day 02, Day 05, Day 10, Day 15, Day 30, Day 45, Day 46 and Day 47 Participant‐perceived efficacy and satisfaction using a Participant Satisfaction QuestionnaireTimepoint: Day 01 ‐ Before and after product application, Day 02, Day 05, Day 10, Day 15, Day 30, Day 45, Day 46 and Day 47 INCLUSION CRITERIA: 1. Healthy Indian adult males and non‐pregnant or non‐lactating females. 2. Participants with mild to moderate body odor, as assessed by an olfactory expert panel. 3. Participants presenting with visible axillary pigmentation. 4. Participants representing varied skin types. 5. Participants who are willing to refrain from using any other axillary products, including antiperspirants, deodorants, fragranced soaps other than permitted, body sprays, powders, or similar products during the study period. 6. Participants who are willing to avoid washing or bathing or wetting the axillary area on specified days during the study. 7. Participants who have completed the required conditioning period prior to baseline assessments.